Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation

被引:93
|
作者
Curtis, MJ
机构
[1] Kings Coll, Cardiovasc Res Labs, Vasc Biol Res Ctr, Cardiovasc IRG, London SW3 6LX, England
[2] Kings Coll, Pharmacol Grp, London SW3 6LX, England
基金
英国惠康基金;
关键词
antifibrillatory drugs; arrhythmia models; global ischaemia; ischaemia; Langendorff preparation; sudden cardiac death; ventricular fibrillation; working heart preparation;
D O I
10.1016/S0008-6363(98)00083-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The isolated perfused heart has been used increasingly during the last decade as a model for identifying actions of drugs on ventricular fibrillation (VF) induced by myocardial ischaemia. In addition, it has been used to explore the mechanisms responsible for the initiation and maintenance of VF, the concept of endogenous myocardial protection and the phenomenon of preconditioning. This article is a review of the available data (effects of drugs, sources of variation, comparison with other models and man, etc.) and an attempt to evaluate the possible clinical relevance. For several reasons, it is not possible to make a precise judgement on the absolute value of the model in terms of its ability to accurately predict the effectiveness of drugs in the prevention of sudden cardiac death, the main reason being the lack of a positive control, i.e. a drug with proven effectiveness against sudden cardiac death caused by VF in man. Nevertheless, the means by which one may reliably and reproducibly generate ischaemia-induced VF in different isolated heart preparations, and the factors (such as species, heart rate, perfusion constituents and involved zone size) that determine the incidence of VF are now well documented. Careful selection of species and experimental conditions permits the isolated heart of smaller inexpensive animals to function as a first line model for detecting anti-VF activity of probable relevance to phase 1 arrhythmogenesis (i.e., arrhythmogenesis during the first 30 min of ischaemia). In view of the absence of a clinical template from which to evaluate how well it predicts drug effectiveness in man, this model's clinical relevance, like that of all other preparations and models, can yet be neither accepted nor dismissed. Recent publication patterns suggest an increasing use of the model. Therefore, recommendations are made to facilitate its effective use. (C) 1998 Elsevier Science BN. All rights reserved.
引用
收藏
页码:194 / 215
页数:22
相关论文
共 50 条
  • [1] Phase 2 ischaemia-induced ventricular fibrillation in the rat isolated blood-perfused heart
    Clements-Jewery, H
    Curtis, MJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135
  • [2] Characterisation of mexiletine’s translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart
    Louise M. Hesketh
    Catherine D. E. Wilder
    Niraja N. Ranadive
    Georgia Lytra
    Patrisia Qazimi
    Jade S. Munro
    Nakita Ahdi
    Michael J. Curtis
    Scientific Reports, 10
  • [3] Characterisation of mexiletine's translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart
    Hesketh, Louise M.
    Wilder, Catherine D. E.
    Ranadive, Niraja N.
    Lytra, Georgia
    Qazimi, Patrisia
    Munro, Jade S.
    Ahdi, Nakita
    Curtis, Michael J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [4] Effect of mexiletine on ischaemia-induced ventricular fibrillation versus its off target actions in the rat isolated heart
    Hesketh, L. M.
    Ranadive, N.
    Ahdi, N.
    Curtis, M. J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (07) : 1628 - 1630
  • [5] Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts
    Hassanabad, ZF
    Furman, BL
    Parratt, JR
    Aughey, E
    BASIC RESEARCH IN CARDIOLOGY, 1998, 93 (04) : 241 - 249
  • [6] Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts
    Z.F. Hassanabad
    B.L. Furman
    J.R. Parratt
    E. Aughey
    Basic Research in Cardiology, 1998, 93 : 241 - 249
  • [7] Mechanisms of preventive effect of nicorandil on ischaemia-induced ventricular tachyarrhythmia in isolated arterially perfused canine left ventricular wedges
    Hirose, Masamichi
    Tsujino, Natsuko
    Nakada, Tsutomu
    Yano, Shiharu
    Imamura, Hiroshi
    Yamada, Mitsuhiko
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 102 (06) : 504 - 514
  • [8] Development of a mouse isolated heart model of ischaemia induced ventricular fibrillation
    Stables, C. L.
    Avkiran, M.
    Curtis, M. J.
    HEART, 2007, 93 (11)
  • [9] Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation
    Stables, Catherine L.
    Curtis, Michael J.
    CARDIOVASCULAR RESEARCH, 2009, 83 (02) : 397 - 404
  • [10] Facilitation of ischaemia-induced ventricular fibrillation by catecholamines is mediated by β1 and β2 agonism in the rat heart in vitro
    Wilder, Catherine D. E.
    Pavlaki, Nikoleta
    Dursun, Tutku
    Gyimah, Paul
    Caldwell-Dunn, Ellice
    Ranieri, Antonella
    Lewis, Hannah R.
    Curtis, Michael J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (10) : 1669 - 1690